Novartis AG

( )
NVS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.51%51.740.9%$2185.75m
JNJJohnson & Johnson 0.26%163.370.7%$1368.59m
MRKMerck & Co., Inc. -1.55%72.280.7%$1045.98m
BMYBristol-Myers Squibb Co. 0.50%57.121.0%$821.40m
LLYEli Lilly & Co. -0.47%245.181.1%$704.90m
ABBVAbbVie, Inc. 0.12%121.501.9%$637.74m
AZNAstraZeneca Plc -1.17%54.761.0%$308.93m
NVSNovartis AG 0.19%80.680.2%$173.62m
GSKGlaxoSmithKline Plc 1.51%42.390.2%$161.58m
DRNADicerna Pharmaceuticals, Inc. -0.05%38.160.3%$155.25m
VTRSViatris, Inc. -0.32%12.400.0%$148.00m
RPRXRoyalty Pharma Plc 1.74%38.550.1%$119.40m
BFRIBiofrontera, Inc. 2.82%4.370.0%$116.32m
RGENRepligen Corp. 4.48%258.676.7%$97.18m
NVONovo Nordisk A/S 2.24%110.160.1%$84.66m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.